Delivery Order SPE2DB22D2206-SPE2DB25FFF04
Award Date
1/23/25
Potential Completion Date
2/13/25
Potential Value
$4.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order valued at $5,053.45 for the supply of MEKINIST 0.05 MG/ML SOLUTION 90ML, a pharmaceutical product. The contract has an ultimate completion date of January 10, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen, the prime contractor, is a for-profit organization registered in the System for Award Management...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of MEKINIST 0.05 MG/ML SOLUTION 90ML, a pharmaceutical product. The contract has a ceiling value of $5,053.45 and is a firm-fixed-price contract. The ultimate completion date is September 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,460.92 firm fixed-price delivery order is for the supply of MEKINIST 0.05 MG/ML SOLUTION 90ML, a specialty pharmaceutical product. The contract has an ultimate completion date of March 13, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $6,691.38 with a completion date of January 27, 2025. It is for the supply of MEKINIST 0.05 MG/ML SOLUTION 90ML, a specialty pharmaceutical product. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide MEKINIST 0.05 MG/ML SOLUTION 90ML, a pharmaceutical product. The award has a ceiling value of $4,042.76 and a performance period through April 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of up to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,552.49, is for the delivery of 4566883401 - MEKINIST 0.5 MG TABLET UU 30S. The contract has an ultimate completion date of January 31, 2025 and was awarded on January 9, 2025. The contract does not have a set-aside designation, indicating it was open competition....
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of MEKINIST 0.05 MG/ML SOLUTION 90ML pharmaceutical products. The contract is a firm-fixed price, with a ceiling value of $6,064.14 and an ultimate completion date of August 22, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a wide range of...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $58,318.41, is for the delivery of MEKINIST 2 MG TABLET UU 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 7, 2025. The award does not have a set-aside designation, indicating open competition....
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a pharmaceutical product - MEKINIST 0.05 MG/ML SOLUTION 90ML. The contract has a ceiling value of $5,053.45 and a period of performance through April 5, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. Additionally, Amerisourcebergen Drug Corp holds an...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MEKINIST 2 MG TABLET UU 30S, a prescription medication. The award, valued at $17,757.60, has an ultimate completion date of August 28, 2024. It is a firm-fixed-price contract and does not have a set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...